COVID-19 susceptibility and severity for dyslipidemia: A mendelian randomization investigation
Background: The severe acute respiratory syndrome coronavirus in 2019 (COVID-19) is still spreading and causing deaths worldwide, which further increased the burden of chronic diseases. Dyslipidemia is a common metabolic syndrome, which is a major risk factor for cardiovascular disease. However, stu...
Main Authors: | Yi Liang, Liang Liu, Bo Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023074558 |
Similar Items
-
Carnitine and COVID-19 Susceptibility and Severity: A Mendelian Randomization Study
by: Chunyu Li, et al.
Published: (2021-11-01) -
Causal relationships between rheumatism and dyslipidemia: A two-sample Mendelian randomization study
by: Guangyang Zhang, et al.
Published: (2022-08-01) -
Mendelian randomization reveals no causal relationship between COVID‐19 susceptibility, hospitalization, or severity and epilepsy
by: Zihua He, et al.
Published: (2023-12-01) -
Cancer and COVID-19 Susceptibility and Severity: A Two-Sample Mendelian Randomization and Bioinformatic Analysis
by: Yiyin Zhang, et al.
Published: (2022-01-01) -
Assessing causality between obstructive sleep apnea with the dyslipidemia and osteoporosis: a Mendelian randomization study
by: Ping-Yang Hong, et al.
Published: (2024-06-01)